The consistent focus of Dr. Anna Gloyn's research has been using naturally occurring mutations in humans as tools to identity critical regulatory pathways and insights into normal physiology. Her early post-doctoral research led to the identification a new genetic aetiology for permanent and transient neonatal diabetes due to KCNJ11 mutations and resulted in one of the first examples of precision medicine, where the determination of the molecular genetic aetiology lead to improved treatment options for patients. Whilst she was in Oxford, Dr.

Awarded in 2018
Home Department: Chemistry
Faculty Advisors: Justin Du Bois (Chemistry) and John Huguenard (Neurology & Neurological Sciences)

Awarded in 2015
Home Department: Chemical & Systems Biology
Faculty Advisors: Daria Mochly-Rosen (Chemical & Systems Biology) and KC Huang (Bioengineering, Microbiology & Immunology)

Dr. Arvin's laboratory investigates the molecular virology of VZV, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in SCID mouse models of VZV infection in vivo.